EFG
TMO icon

Ethos Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Ethos Financial Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$496K Buy
861
+266
+45% +$128K 0.03% 366
2026
Q1 		$293K Sell
595
-484
-45% -$263K 0.02% 409
2025
Q4 		$626K Buy
1,079
+653
+153% +$369K 0.05% 259
2025
Q3 		$207K Buy
+426
New +$198K 0.02% 443

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ethos Financial Group's TMO Position: Q2 2026 in Review

Ethos Financial Group increased its Thermo Fisher Scientific (TMO) stake by 45% in Q2 2026, buying an estimated $128K and bringing the position to 861 shares worth $496K. The position accounts for 0.03% of the portfolio, ranked #366.

Ethos Financial Group first reported a position in TMO in Q3 2025 and has held it in 4 quarters since. The position peaked at $626K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ethos Financial Group held 861 shares of Thermo Fisher Scientific worth $496K as of Q2 2026.
  • Ethos Financial Group bought 266 Thermo Fisher Scientific shares in Q2 2026, an estimated $128K.
  • Thermo Fisher Scientific made up 0.03% of Ethos Financial Group's portfolio in Q2 2026, its #366 holding.
  • Ethos Financial Group first reported a position in Thermo Fisher Scientific in Q3 2025 and has held it in 4 quarters since.
  • Ethos Financial Group's Thermo Fisher Scientific position peaked at $626K in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ethos Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.